サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：男性不妊症診断・治療の世界市場（2022年～2028年）
市場調査レポート
商品コード
1078045

男性不妊症診断・治療の世界市場（2022年～2028年）

Global Male Infertility Diagnosis and Treatment Market 2022-2028
出版日: | 発行: Orion Market Research | ページ情報: 英文 110 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.85円
男性不妊症診断・治療の世界市場（2022年～2028年）
出版日: 2022年04月13日
発行: Orion Market Research
ページ情報: 英文 110 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の男性不妊症診断・治療の市場規模は、予測期間中にCAGRで4%の大幅な成長が予測されています。

当レポートでは、世界の男性不妊症診断・治療市場について調査分析し、市場概要、競合情勢、セグメント分析、地域分析などを提供しています。

目次

第1章 レポートサマリー

第2章 市場概要と考察

  • 調査範囲
  • アナリストの考察と現在の市場動向

第3章 競合情勢

  • 主要企業分析
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の発展
  • 主要戦略分析
  • 主要企業に対するCOVID-19の影響

第4章 市場セグメンテーション

  • 世界の男性不妊症診断・治療市場：診断検査別
    • 精液分析
    • 尿検査
    • 遺伝子検査
    • 精巣生検
    • ホルモン検査
    • その他
  • 世界の男性不妊症診断・治療市場：治療別
    • 薬物
    • 抗レトロウイルス療法（ART）
    • 手術

第5章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他の欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他のアジア太平洋
  • その他の地域

第6章 企業プロファイル

  • AndroviaLifeSciences
  • ASKA Pharmaceutical Co., Ltd.
  • AytuBioScience, Inc.
  • Bayer AG
  • Bristol-Myers Squibb Co.
  • Cadila Pharmaceuticals Ltd.
  • Centogene AG
  • Cook Medical, Inc.
  • CooperSurgical Fertility & Genomic Solutions
  • Eli Lilly and Co.
  • FUJIFILM Irvine Scientific
  • Halotech DNA SL
  • IntasPharmaceuticals Ltd.
  • Merck KGaA
  • PerkinElmer, Inc.
  • Pfizer, Inc.
  • Sanofi S.A.
  • SCSA Diagnostics, Inc.
  • Vitrolife AB
図表

LIST OF TABLES

  • 1. GLOBAL MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TESTS, 2021-2028 ($ MILLION)
  • 2. GLOBALSEMEN ANALYSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 3. GLOBAL URINALYSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 4. GLOBAL GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 5. GLOBAL TESTICULAR BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 6. GLOBAL HORMONAL TESTS MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 7. GLOBAL OTHER MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 8. GLOBAL MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)
  • 9. GLOBAL DRUGS FOR MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 10. GLOBAL ART FOR MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 11. GLOBAL SURGERY FOR MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 12. GLOBAL MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
  • 13. NORTH AMERICAN MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 14. NORTH AMERICAN MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TESTS, 2021-2028 ($ MILLION)
  • 15. NORTH AMERICAN MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)
  • 16. EUROPEAN MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 17. EUROPEAN MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TESTS, 2021-2028 ($ MILLION)
  • 18. EUROPEAN MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)
  • 19. ASIA-PACIFIC MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 20. ASIA-PACIFIC MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TESTS, 2021-2028 ($ MILLION)
  • 21. ASIA-PACIFIC MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)
  • 22. REST OF THE WORLD MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 23. REST OF THE WORLD MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TESTS, 2021-2028 ($ MILLION)
  • 24. REST OF THE WORLD MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET, 2021-2028 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET BY SEGMENT, 2021-2028 ($ MILLION)
  • 3. RECOVERY OF GLOBAL MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET, 2022-2028 (%)
  • 4. GLOBAL MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SHARE BY DIAGNOSTIC TESTS, 2021 VS 2028 (%)
  • 5. GLOBAL SEMEN ANALYSIS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 6. GLOBAL URINALYSIS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 7. GLOBAL GENETIC TESTING MICROWAVE ABLATION MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 8. GLOBAL TESTICULAR BIOPSY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 9. GLOBAL HORMONAL TESTS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 10. GLOBAL OTHERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 11. GLOBAL MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SHARE BY TREATMENT, 2021 VS 2028 (%)
  • 12. GLOBAL DRUGS FOR MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 13. GLOBAL ARTFOR MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 14. GLOBAL SURGERY FOR MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 15. US MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 16. CANADA MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 17. UK MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 18. FRANCE MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 19. GERMANY MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 20. ITALY MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 21. SPAIN MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 22. REST OF EUROPE MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 23. INDIA MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 24. CHINA MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 25. JAPAN MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 26. SOUTH KOREA MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 27. REST OF ASIA-PACIFIC MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
  • 28. REST OF THE WORLD MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
目次
Product Code: OMR2017111

Global Male Infertility Diagnosis and Treatment Market Size, Share & Trends Analysis Report By Diagnostic Tests (Semen Analysis, Urinalysis, Genetic Testing, Testicular Biopsy, Hormonal Tests, and Others) By Treatment (Drugs, ART Therapy, and Surgery) Forecast Period (2022-2028)

The global male infertility diagnosis and treatment market is anticipated to grow at a significant CAGR of 4% during the forecast period. Erectile dysfunction, varicocele, sperm difficulties, and clogged tubes are all common reasons of male infertility. This, in turn, is driving up demand for male infertility diagnostic tests and treatment options, which help doctors better understand the reason of infertility and, as a result, provide more accurate treatment recommendations. Semen analysis, urinalysis, and hormonal tests are the most common diagnostic tests used to determine the aetiology of male infertility. FSH (follicle-stimulating hormone) and testosterone levels are measured in hormonal testing to detect the overall hormonal system balance and the condition of sperm production. When initial tests indicate that these tests are needed, prolactin and serum LH are two hormonal tests that may be conducted.

The global male infertility diagnosis and treatment market is segmented based on diagnostic tests and treatment. Based on diagnostic tests, the market is classified into semen analysis, urinalysis, genetic testing, testicular biopsy, hormonal tests, and others. Based on treatment, the market is segmented into drugs, ART therapy, and surgery.

The global male infertility diagnosis and treatment market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). The market can be analyzed for a particular region or country level as per the requirement. Among these, the Asia-Pacific regional market is expected to cater to considerable growth during the forecast period owing to significant incidences of infertility coupled with initiatives to promote awareness for diagnosis and treatment of the conditionFor instance, ASPIRE, the Asia Pacific Initiative on Reproduction, was founded in 2001 by Bruno Lunenfeld and P C Wong. The initiative is aimed at improving the knowledge and awareness of ART and infertility-related services that can support to improve the quality of patient care. Additionally, this is intended to develop and advance fertility services in the region and raise awareness and understanding for infertility treatment alternatives among healthcare professionals and the public.

The major companies serving the global male infertility diagnosis and treatment market include Merck KGaA, Halotech DNA SL, PerkinElmer, Inc., Vitrolife AB, and Medical Electronic Systems. among others.

Research Methodology

The market study of the global male infertility diagnosis and treatment market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of the market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Male Infertility Diagnosis and Treatment Market Research and Analysis by Diagnostic Tests

2. Global Male Infertility Diagnosis and Treatment Market Research and Analysis by Treatment

The Report Covers

  • Comprehensive research methodology of the global male infertility diagnosis and treatment market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the male infertility diagnosis and treatment market.
  • Insights about market determinants that are stimulating the global male infertility diagnosis and treatment market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

Category- Biotechnology

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Male Infertility Diagnosis and Treatment Market
  • Recovery Scenario of Global Male Infertility Diagnosis and Treatment Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. ByRegion

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis
  • 3.3. Impact of Covid-19 on Key Players

4. Market Segmentation

  • 4.1. Global Male Infertility Diagnosis and Treatment Market by Diagnostic Tests
    • 4.1.1. Semen Analysis
    • 4.1.2. Urinalysis
    • 4.1.3. Genetic Testing
    • 4.1.4. Testicular Biopsy
    • 4.1.5. Hormonal Tests
    • 4.1.6. Others
  • 4.2. Global Male Infertility Diagnosis and Treatment Market by Treatment
    • 4.2.1. Drugs
    • 4.2.2. Anti-Retroviral Therapy (ART)
    • 4.2.3. Surgery

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. AndroviaLifeSciences
  • 6.2. ASKA Pharmaceutical Co., Ltd.
  • 6.3. AytuBioScience, Inc.
  • 6.4. Bayer AG
  • 6.5. Bristol-Myers Squibb Co.
  • 6.6. Cadila Pharmaceuticals Ltd.
  • 6.7. Centogene AG
  • 6.8. Cook Medical, Inc.
  • 6.9. CooperSurgical Fertility & Genomic Solutions
  • 6.10. Eli Lilly and Co.
  • 6.11. FUJIFILM Irvine Scientific
  • 6.12. Halotech DNA SL
  • 6.13. IntasPharmaceuticals Ltd.
  • 6.14. Merck KGaA
  • 6.15. PerkinElmer, Inc.
  • 6.16. Pfizer, Inc.
  • 6.17. Sanofi S.A.
  • 6.18. SCSA Diagnostics, Inc.
  • 6.19. Vitrolife AB